It's time to personalize and optimize lipid-lowering therapy

Eur Heart J. 2020 Jul 21;41(28):2629-2631. doi: 10.1093/eurheartj/ehaa445.

Authors

Oliver Weingärtner¹, Shailesh B Patel², Dieter Lütjohann³

Affiliations

¹ Klinik für Innere Medizin I, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Jena, Germany.
² Division of Endocrinology, Diabetes and Metabolism, University of Cincinnati, Cincinnati, OH, USA.
³ Institut für Klinische Chemie und Klinische Pharmakologie, Universitätsklinikum Bonn, Bonn, Germany.

PMID: 32702747
DOI: 10.1093/eurheartj/ehaa445

No abstract available

Publication types

Editorial
Comment

MeSH terms

Coronary Artery Disease*
Humans
Sterols

Substances

Sterols